0001209191-22-038764.txt : 20220622
0001209191-22-038764.hdr.sgml : 20220622
20220622190145
ACCESSION NUMBER: 0001209191-22-038764
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220621
FILED AS OF DATE: 20220622
DATE AS OF CHANGE: 20220622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Campbell Bradley L
CENTRAL INDEX KEY: 0001400971
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 221033231
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
BUSINESS PHONE: (215) 921-7600
MAIL ADDRESS:
STREET 1: 3675 MARKET STREET
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
FORMER COMPANY:
FORMER CONFORMED NAME: AMICUS THERAPEUTICS INC
DATE OF NAME CHANGE: 20020729
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-21
0
0001178879
AMICUS THERAPEUTICS, INC.
FOLD
0001400971
Campbell Bradley L
C/O AMICUS THERAPEUTICS, INC.
3675 MARKET STREET
PHILADELPHIA
PA
19104
1
1
0
0
Chief Operating Officer
Common Stock
2022-06-21
4
M
0
16410
3.53
A
706028
D
Common Stock
2022-06-21
4
S
0
16410
10.00
D
689618
D
Stock Options (right to buy)
3.53
2022-06-21
4
M
0
16410
0.00
D
2023-01-28
Common Stock
16410
32835
D
The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
All of the options were fully vested and exercisable as of the transaction date.
/s/ Christian Formica, Attorney-in-Fact
2022-06-22